(19)
(11) EP 2 012 797 A2

(12)

(43) Date of publication:
14.01.2009 Bulletin 2009/03

(21) Application number: 07758963.8

(22) Date of filing: 21.03.2007
(51) International Patent Classification (IPC): 
A61K 31/58(2006.01)
A61L 2/23(2006.01)
(86) International application number:
PCT/US2007/064462
(87) International publication number:
WO 2007/109698 (27.09.2007 Gazette 2007/39)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 22.03.2006 US 784634 P

(71) Applicants:
  • GLAXO GROUP LIMITED
    Greenford, Middlesex UB6 0NN (GB)
  • 3M Innovative Properties Company
    St. Paul MN 55133-3427 (US)

(72) Inventors:
  • CAPECCHI, John
    St. Paul, Minnesota 55133-3427 (US)
  • STEFELY, James
    St. Paul, Minnesota 55133-3427 (US)
  • RILEY, Trevor
    Ware Hertfordshire SG12 0DP (GB)

(74) Representative: Pritchard, Judith et al
GlaxoSmithKline, Corporate Intellectual Property (CN925.1), 980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) NOVEL FORMULATIONS